Fig. 2.

Histopathology of MRDB results per PI‐RADS group. Histopathological outcomes of the total number of men who underwent MRDB due to suspicious MRI (1067/2597 men) and per PI‐RADS category. In total, 81% of men (869/1067) who underwent MRDB had prostate cancer, 63% (668/1067) and 35% (373/1067) had GG ≥2 and GG ≥3 cancer, respectively, in other words, the positive predictive value of MRDB. Outcomes of separate PI‐RADS scores show higher PI‐RADS scores (i.e. greater likelihood of clinically significant prostate cancer) result in increasing rates of GG ≥2 and GG ≥3 cancer.